Regulation of normal cell cycle progression by flavin-containing oxidases

Oncogene

Volumn 27, Issue 1, 2008, Pages 20-31

  Venkatachalam, P ^a   De Toledo, S M ^a   Pandey, B N ^a   Tephly, L A ^b   Carter, A B ^b   Little, J B ^c   Spitz, D R ^b   Azzam, E I ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

ATM p53 p21Waf1 p38MAPK cyclin D1; Cellular proliferation G1 checkpoint G2 checkpoint; Flavin containing oxidases; NAD(P)H oxidase nitric oxide synthase; Reactive oxygen species

Indexed keywords

ATM PROTEIN; CHECKPOINT KINASE 1; CYCLIN DEPENDENT KINASE INHIBITOR 1; DIPHENYLIODONIUM SALT; FLAVIN CONTAINING OXIDASE; FLAVOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE SYNTHASE; OXIDOREDUCTASE; PROTEIN INHIBITOR; PROTEIN P21; PROTEIN P53; PROTEIN PHOX91; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CYCLE G2 PHASE; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; ENZYME REGULATION; FIBROBLAST; GAMMA RADIATION; GENE TARGETING; HUMAN; HUMAN CELL; INCUBATION TIME; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE;

ANIMALS; CELL CYCLE; CELL LINE; CELL SURVIVAL; CELLS, CULTURED; FIBROBLASTS; FLAVINS; GROWTH INHIBITORS; HUMANS; MEMBRANE POTENTIALS; MICE; MICE, INBRED C3H; MITOCHONDRIAL PROTEINS; NADPH OXIDASE; ONIUM COMPOUNDS; OXIDATION-REDUCTION; SIGNAL TRANSDUCTION;

RODENTIA;

EID: 37849046109     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1210634     Document Type: Article

References (56)

1. Agami R, Bernards R. (2002). Convergence of mitogenic and DNA damage signaling in the G1 phase of the cell cycle. Cancer Lett 177: 111-118.
2. Ammendola R, Ruocchio MR, Chirico G, Russo L, De Felice C, Esposito F et al. (2002). Inhibition of NADH/NADPH oxidase affects signal transduction by growth factor receptors in normal fibroblasts. Arch Biochem Biophys 397: 253-257.
3. Azzam EI, de Toledo SM, Pykett MJ, Nagasawa H, Little JB. (1997). Cdc2 is down-regulated by ionizing radiation in a p53-dependent manner. Cell Growth Differ 8: 1161-1169.
4. Azzam EI, de Toledo SM, Raaphorst GP, Mitchel RE. (1996). Low-dose ionizing radiation decreases the frequency of neoplastic transformation to a level below the spontaneous rate in C3H 10T1/2 cells. Radiat Res 146: 369-373.
5. Azzam EI, de Toledo SM, Spitz DR, Little JB. (2002). Oxidative metabolism modulates signal transduction and micronucleus formation in bystander cells from alpha-particle-irradiated normal human fibroblast cultures. Cancer Res 62: 5436-5442.
6. Azzam EI, de Toledo SM, Waker AJ, Little JB. (2000). High and low fluences of alpha-particles induce a G1 checkpoint in human diploid fibroblasts. Cancer Res 60: 2623-2631.
7. Babior BM. (1999). NADPH oxidase: an update. Blood 93: 1464-1476.
8. Bae YS, Kang SW, Seo MS, Baines IC, Tekle E, Chock PB et al. (1997). Epidermal growth factor (EGF)-induced generation of hydrogen peroxide. Role in EGF receptor-mediated tyrosine phosphorylation. J Biol Chem 272: 217-221.
9. Begg AC, McNally NJ, Shrieve DC, Karcher H. (1985). A method to measure the duration of DNA synthesis and the potential doubling time from a single sample. Cytometry 6: 620-626.
10. Burdon RH. (1995). Superoxide and hydrogen peroxide in relation to mammalian cell proliferation. Free Rad Biol Med 18: 775-794.
11. Cals-Grierson MM, Ormerod AD. (2004). Nitric oxide function in the skin. Nitric Oxide 10: 179-193.
12. Cheng M, Olivier P, Diehl JA, Fero M, Roussel MF, Roberts JM et al. (1999). The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J 18: 1571-1583.
13. Cho KR, Vogelstein B. (1992). Genetic alterations in the adenomacarcinoma sequence. Cancer 70: 1727-1731.
14. Cross AR, Jones OT. (1986). The effect of the inhibitor diphenylene iodonium on the superoxide-generating system of neutrophils. Specific labelling of a component polypeptide of the oxidase. Biochem J 237: 111-116.
15. de Toledo SM, Asaad N, Venkatachalam P, Li L, Spitz DR, Azzam EI. (2006). Adaptive responses to low-dose/low-dose-rate gamma rays in normal human fibroblasts: the role of growth architecture and oxidative metabolism. Radiat Res 166: 849-857.
16. de Toledo SM, Azzam EI, Dahlberg WK, Gooding TB, Little JB. (2000). ATM complexes with HDM2 and promotes its rapid phosphorylation in a p53-independent manner in normal and tumor human cells exposed to ionizing radiation. Oncogene 19: 6185-6193.
17. de Toledo SM, Azzam EI, Keng P, Laffrenier S, Little JB. (1998). Regulation by ionizing radiation of CDC2, cyclin A, cyclin B, thymidine kinase, topoisomerase IIalpha, and RAD51 expression in normal human diploid fibroblasts is dependent on p53/p21Waf1. Cell Growth Differ 9: 887-896.
18. Deng C, Zhang P, Harper JW, Elledge SJ, Leder P. (1995). Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82: 675-684.
19. Dent P, Yacoub A, Fisher PB, Hagan MP, Grant S. (2003). MAPK pathways in radiation responses. Oncogene 22: 5885-5896.
20. Diehl JA, Cheng M, Roussel MF, Sherr CJ. (1998). Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev 12: 3499-3511.
21. Dietz S, Rother K, Bamberger C, Schmale H, Mossner J, Engeland K. (2002). Differential regulation of transcription and induction of programmed cell death by human p53-family members p63 and p73. FEBS Lett 525: 93-99.
22. Doussiere J, Vignais PV. (1992). Diphenylene iodonium as an inhibitor of the NADPH oxidase complex of bovine neutrophils. Factors controlling the inhibitory potency of diphenylene iodonium in a cell-free system of oxidase activation. Eur J Biochem 208: 61-71.
23. Droge W. (2002). Free radicals in the physiological control of cell function. Physiol Rev 82: 47-95.
24. Esposito F, Russo L, Chirico G, Ammendola R, Russo T, Cimino F. (2001). Regulation of p21waf1/cip1 expression by intracellular redox conditions. IUBMB Life 52: 67-70.
25. Fenech M, Morley AA. (1985). Measurement of micronuclei in lymphocytes. Mutat Res 147: 29-36.
26. Frigo DE, Basu A, Nierth-Simpson EN, Weldon CB, Dugan CM, Elliott S et al. (2006). p38 mitogen-activated protein kinase stimulates estrogen-mediated transcription and proliferation through the phosphorylation and potentiation of the p160 coactivator glucocorticoid receptor-interacting protein 1. Mol Endocrinol 20: 971-983.
27. Gordon DM, Dancis A, Pain D. (2000). Mechanisms of mitochondrial protein import. Essays Biochem 36: 61-73.
28. Halliwell B. (1996). Free radicals, proteins and DNA: oxidative damage versus redox regulation. Biochem Soc Trans 24: 1023-1027.
29. Hempel SL, Buettner GR, O'Malley YQ, Wessels DA, Flaherty DM. (1999). Dihydrofluorescein diacetate is superior for detecting intracellular oxidants: comparison with 2′,7′-dichlorodihydrofluorescein diacetate, 5(and 6)-carboxy-2′,7′-dichlorodihydrofluorescein diacetate, and dihydrorhodamine 123. Free Radic Biol Med 27: 146-159.
30. Irani K, Goldschmidt-Clermont PJ. (1998). Ras, superoxide and signal transduction. Biochem Pharmacol 55: 1339-1346.
31. Juretic N, Santibanez JF, Hurtado C, Martinez J. (2001). ERK 1,2 and p38 pathways are involved in the proliferative stimuli mediated by urokinase in osteoblastic SaOS-2 cell line. J Cell Biochem 83: 92-98.
32. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW. (1991). Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51: 6304-6311.
33. Kastan MB, Zhan Q, el-Deiry WS, Carrier F, Jacks T, Walsh WV et al. (1992). A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71: 587-597.
34. Lavin MF, Khanna KK. (1999). ATM: the protein encoded by the gene mutated in the radiosensitive syndrome ataxia-telangiectasia. Int J Radiat Biol 75: 1201-1214.
35. Lavoie JN, L'Allemain G, Brunet A, Muller R, Pouyssegur J. (1996). Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway. J Biol Chem 271: 20608-20616.
36. 2. Production by a non-phagocytic NAD(P)H oxidase causes oxidant injury. J Biol Chem 17: 17.
37. Little JB. (1968). Delayed initiation of DNA synthesis in irradiated human diploid cells. Nature 218: 1064-1065.
38. Little JB. (1994). Failla memorial lecture. Changing views of cellular radiosensitivity. Radiat Res 140: 299-311.
39. Little JB. (2000). Radiation carcinogenesis. Carcinogenesis 21: 394-404.
40. Maki CG, Huibregtse JM, Howley PM. (1996). In vivo ubiquitination and proteasome-mediated degradation of p53(1). Cancer Res 56: 2649-2654.
41. Matsumoto H, Hamada N, Takahashi A, Kobayashi Y, Ohnishi T. (2007). Vanguards of paradigm shift in radiation biology: radiation-induced adaptive and bystander responses. J Radiat Res (Tokyo) 48: 97-106.
42. Matsushime H, Ewen ME, Strom DK, Kato JY, Hanks SK, Roussel MF et al. (1992). Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins. Cell 71: 323-334.
43. Menon SG, Sarsour EH, Spitz DR, Higashikubo R, Sturm M, Zhang H et al. (2003). Redox regulation of the G1 to S phase transition in the mouse embryo fibroblast cell cycle. Cancer Res 63: 2109-2117.
44. Murrell GA, Francis MJ, Bromley L. (1990). Modulation of fibroblast proliferation by oxygen free radicals. Biochem J 265: 659-665.
45. Nagasawa H, Li CY, Maki CG, Imrich AC, Little JB. (1995). Relationship between radiation-induced G1 phase arrest and p53 function in human tumor cells. Cancer Res 55: 1842-1846.
46. Ono K, Han J. (2000). The p38 signal transduction pathway: activation and function. Cell Signal 12: 1-13.
47. Pandey BN, Gordon DA, Pain D, Azzam EI. (2006). Normal human fibroblasts exposed to high or low dose ionizing radiation: differential effects on mitochondrial protein import and membrane potential. Antioxid Redox Signal 8: 1253-1261.
48. Schafer FQ, Buettner GR. (2001). Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med 30: 1191-1212.
49. Schulze-Osthoff K, Bauer M, Vogt M, Wesselborg S, Baeuerle PA. (1997). Reactive oxygen intermediates as primary signals and second messengers in the activation of transcription factors. In: Forman Hj and Cadenas E (eds). Oxidative Stress and Signal Transduction. Chapman & Hall: New York, pp 239-259.
50. Spitz DR, Azzam EI, Li JJ, Gius D. (2004). Metabolic oxidation/reduction reactions and cellular responses to ionizing radiation: a unifying concept in stress response biology. Cancer Metastasis Rev 23: 311-322.
51. Stuehr DJ, Fasehun OA, Kwon NS, Gross SS, Gonzalez JA, Levi R et al. (1991). Inhibition of macrophage and endothelial cell nitric oxide synthase by diphenyleneiodonium and its analogs. Faseb J 5: 98-103.
52. Szatrowski TP, Nathan CF. (1991). Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res 51: 794-798.
53. Terasima R, Tolmach LJ. (1963). X-ray sensitivity and DNA synthesis in synchronous populations of Hela cells. Science 140: 490-492.
54. Ushio-Fukai M, Zafari AM, Fukui T, Ishizaka N, Griendling KK. (1996). p22phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells. J Biol Chem 271: 23317-23321.
55. Yam CH, Fung TK, Poon RY. (2002). Cyclin A in cell cycle control and cancer. Cell Mol Life Sci 59: 1317-1326.
56. Yoon S, Seger R. (2006). The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions. Growth Factors 24: 21-44.